Table 3 Overview of radiopharmaceuticals
| Tracer | Intended usea |
|---|---|
| 18F-fluorodeoxyglucose (18F-FDG) | Visualization of increased glucose metabolism / inflammatory activity [36] |
| 18F-3′-fluoro-3′-deoxy-L-thymidine (18F-FLT) | Visualization of DNA-synthesis / cellular proliferation [37] |
|
Labeled colloids 99mTc, 198Au, 113mIn | Visualization of reticuloendothelial system / medullary stroma [25, 39] |
| 111In-Chloride (111In-Cl3) | Visualization of erythropoietic activity [39] |
|
Labeled iron 59Fe, 52Fe | Visualization of erythropoietic marrow [40, 45] |
|
Labeled red blood cells (RBC’s) 99mTc or 113mIn | Visualization of RBC pools; heat-damaged RBC’s for assessment of spleen volume [71] |
| 99mTc-leukocytes | Visualization of hematopoiesis [41] (standard use for detection of inflammation) |
|
99mTc-antigranulocyte antibodies (99mTc-AGAb) | Visualization of granulocyte (precursors) / granulopoeisis [46] |
| 99mTc-low density lipoprotein (99mTc-LDL) | Visualization of LDL biodistribution / catabolism [47] |
|
99mTc-methylene-diphosphonate (99mTc-MDP) | Visualization of bone matrix turnover and/or blood flow [42] |
| 133Xe | Evaluation of blood flow [60] (standard use for ventilation studies) |
| 15O-carbon dioxide (15O-CO2) | Evaluation of blood flow [61] |